Although Maucourant et al. did not find differences in the expression profile of inhibitory KIRs on NK cells or NK cell education in COVID-19 patient compared to controls [193], there are a few reports about specific KIR/HLA-C combinations in COVID-19. This evidence concerns the gene KIR3DL1 and COVID-19.